[MeS07] メディカルセミナー 7　Management of Advanced HCC in the Era of Atezolizumab-Bevacizumab: Current Evidence and Future Perspective

[MeS07-1] Management of Advanced HCC in the Era of Atezolizumab-Bevacizumab: Current Evidence and Future Perspective

^○Changhoon Yoo (Department of Oncology, Asan Medical Center,University of Ulsan College of Medicine, Seoul, South Korea)